No abstract available
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / pharmacology*
-
Cell Line, Tumor
-
Drug Delivery Systems* / methods
-
Drug Resistance, Neoplasm / physiology*
-
Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
-
Extracellular Signal-Regulated MAP Kinases / biosynthesis
-
Extracellular Signal-Regulated MAP Kinases / genetics
-
Hematologic Neoplasms / drug therapy*
-
Hematologic Neoplasms / enzymology
-
Hematologic Neoplasms / metabolism
-
Mice
-
Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
-
Mitogen-Activated Protein Kinase Kinases / biosynthesis
-
Mitogen-Activated Protein Kinase Kinases / genetics
-
Phosphatidylinositol 3-Kinases / biosynthesis
-
Phosphatidylinositol 3-Kinases / genetics
-
Phosphoinositide-3 Kinase Inhibitors
-
Proto-Oncogene Proteins c-akt / antagonists & inhibitors
-
Proto-Oncogene Proteins c-akt / biosynthesis
-
Proto-Oncogene Proteins c-akt / genetics
-
Signal Transduction / drug effects*
-
Signal Transduction / physiology
-
Tumor Suppressor Protein p53 / antagonists & inhibitors
-
Tumor Suppressor Protein p53 / biosynthesis
-
Tumor Suppressor Protein p53 / genetics
-
raf Kinases / antagonists & inhibitors*
-
raf Kinases / biosynthesis
-
raf Kinases / genetics
-
raf Kinases / metabolism
Substances
-
Antineoplastic Agents
-
Phosphoinositide-3 Kinase Inhibitors
-
Tumor Suppressor Protein p53
-
Proto-Oncogene Proteins c-akt
-
raf Kinases
-
Extracellular Signal-Regulated MAP Kinases
-
Mitogen-Activated Protein Kinase Kinases